Novo Nordisk A/S (ETR:NOV)
Germany · Delayed Price · Currency is EUR 49.00
-1.80 (-3.54%)
Oct 10, 2025, 10:50 PM CET
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
€533,459
Profits / Employee
€189,942
Market Cap
224.36B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
| Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
| Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
| Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
| Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,730 |
Novo Nordisk News
- 1 day ago - Novo Nordisk halts work on cell therapy for diabetes to cut costs, Bloomberg News reports - Reuters
- 2 days ago - Novo Nordisk A/S (NVO) M&A Call Transcript - Seeking Alpha
- 2 days ago - Novo Nordisk to acquire Akero Therapeutics for its experimental liver disease drug - Fast Company
- 2 days ago - Novo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion - Benzinga
- 2 days ago - Akero Therapeutics soars after Novo Nordisk set for $5.2B cash acquisition - Invezz
- 2 days ago - Akero Therapeutics Stock Soars on Novo Nordisk Deal. - Barrons
- 2 days ago - Novo Nordisk is paying up to $5.2 billion for a San Francisco biotech working on liver disease - Market Watch
- 2 days ago - Novo Nordisk To Buy Akero Therapeutics for $4.7 Billion - WSJ